Phase II clinical trial of XYOTAX in non-small cell lung cancer to continue.
D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D017322:Clinical Trials, Phase II as Topic; D004361:Drug Tolerance; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D017239:Paclitaxel / Q000031:analogs & derivatives / Q000627:therapeutic use*; D011099:Polyglutamic Acid / Q000627:therapeutic use* / Q000031:analogs & derivatives; D043823:Taxoids
D043823:Taxoids; D011099:Polyglutamic Acid; D017239:Paclitaxel; C509139:paclitaxel poliglumex